Curiox Biosystems has expanded its commercial leadership team and formed a Strategic Advisory Board to accelerate the adoption of its Pluto Workstations. The Workstations utilize the Company’s C-FREE ™ technology to automate flow cytometry sample preparation, eliminating the need for centrifugation during washing and mixing. This approach supports more standardized and reproducible workflows by reducing manual intervention. The expanded commercial team, led by Shanin Barican and Kristine Friscino, will focus on bringing these capabilities to laboratories within the biopharma, CROs, and research institutions sectors. Kristine Friscino brings over 20 years of commercial experience in life science tools, previously holding leadership roles at Nuclera and Abcam. The Strategic Advisory Board includes Elizabeth (Betty) Woo, previously VP of Cell, Gene, and Advanced Therapies at Thermo Fisher Scientific, and David Newble, a life sciences executive with experience at TAP Biosystems and SPT Labtech, to provide guidance on market requirements and industry standards. These appointments are intended to scale the Company to proactively address customer demand and establish centrifuge-free sample preparation as the standard practice.
Curiox Biosystems strengthens commercial leadership to expand adoption of centrifuge-free sample preparation
Curiox Biosystems Inc (Curiox), a provider of centrifuge-free (C-FREE™) sample preparation technologies for reproducible, automated flow cytometry workflows, today announced the expansion of its senior commercial team and the formation of a Strategic Advisory Board (SAB).
Recommended Medical News
All news →
Study discovers shared vocal patterns between birds and humans
McGill University researchers have identified "universal" vocal patterns across hundreds of bird species and found that many of the same patterns also appear in human song and speech from cultures around the world.
ATCC selected by ARPA-H to support next-generation BioStabilization technologies
ATCC has been selected by the Advanced Research Projects Agency for Health (ARPA-H) as an affiliate to provide independent verification and validation (IV&V) for its BioStabilization Systems (BoSS) program.
Mutated neutrophils may trigger immune attacks in lupus
Scientists at La Jolla Institute for Immunology (LJI) and the University of Washington (UW) have discovered that patients with lupus have unusual mutations that may turn their bodies into battlegrounds.
Thyroid cancer risks and medication timing with oral GLP-1s
Like most prescriptions, glucagon-like peptide 1 (GLP-1) medications to manage weight come with potential risks.